Between The Lines

A highly clinical video series that presents curated insights and expert analysis of a peer reviewed publication or presentation, to inform and engage our audience.

With the use of infographics, explore the data as our experts summarize and evaluate results. They will provide valuable insights and perspectives, while bridging the gap between physicians, and academics.

Efficacy and Safety of Subcutaneous Spesolimab for the Prevention of Generalised Pustular Psoriasis Flares (Effisayil 2): an International, Multicentre, Randomised, Placebo-Controlled Trial

Efficacy and Safety of Subcutaneous Spesolimab for the Prevention of Generalised Pustular Psoriasis Flares (Effisayil 2): an International, Multicentre, Randomised, Placebo-Controlled Trial

September 30th 2024
2 KOLs are featured in this series.

Level Up: Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to Severe Atopic Dermatitis: Results of an Open-label, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study

September 5th 2024
Clinical Impact of Topical Ruxolitinib Cream: Physician Satisfaction & Treatment Patterns in Atopic Dermatitis

Clinical Impact of Topical Ruxolitinib Cream: Physician Satisfaction & Treatment Patterns in Atopic Dermatitis

May 21st 2024
Relief from Core AD Symptoms: Topical Cream Treatments for Moderate to Severe Atopic Dermatitis in Adults and Pediatrics

Relief from Core AD Symptoms: Topical Cream Treatments for Moderate to Severe Atopic Dermatitis in Adults and Pediatrics

December 15th 2023
Expert Insights on the Use of Oral JAK Inhibitors for Atopic Dermatitis: Raising the Bar for Standard of Care

Expert Insights on the Use of Oral JAK Inhibitors for Atopic Dermatitis: Raising the Bar for Standard of Care

July 20th 2023
Rapid Pruritus Reduction with Ruxolitinib Cream Treatment in Patients with Atopic Dermatitis

Rapid Pruritus Reduction with Ruxolitinib Cream Treatment in Patients with Atopic Dermatitis

March 29th 2023
Expert Perspective on Long-Term Open-Label Extension Data for Dupilumab in the Treatment of Atopic Dermatitis

Expert Perspective on Long-Term Open-Label Extension Data for Dupilumab in the Treatment of Atopic Dermatitis

December 21st 2022
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records

Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records

November 21st 2022
Between the Lines: The Role of Non-Prescription Products in the Management of Acne

Between the Lines: The Role of Non-Prescription Products in the Management of Acne

August 19th 2022
© 2024 MJH Life Sciences

All rights reserved.